MRTX
|
Mirati Therapeutics, Inc.
|
US
|
NASDAQ
|
MTEM
|
Molecular Templates, Inc.
|
US
|
NASDAQ
|
NBTX
|
Nanobiotix S.A.
|
US
|
NASDAQ
|
NVCR
|
NovoCure Limited
|
US
|
NASDAQ
|
OCX
|
OncoCyte Corporation
|
US
|
NASDAQ
|
ORIC
|
Oric Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
PDSB
|
PDS Biotechnology Corporation
|
US
|
NASDAQ
|
PKBO
|
Peak Bio, Inc.
|
US
|
NASDAQ
|
POAI
|
Predictive Oncology Inc.
|
US
|
NASDAQ
|
SESN
|
Sesen Bio, Inc.
|
US
|
NASDAQ
|
SLRX
|
Salarius Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
SLS
|
SELLAS Life Sciences Group, Inc.
|
US
|
NASDAQ
|
TIL
|
Instil Bio, Inc.
|
US
|
NASDAQ
|
TOI
|
The Oncology Institute, Inc.
|
US
|
NASDAQ
|
VNDA
|
Vanda Pharmaceuticals Inc.
|
US
|
NASDAQ
|
VSTM
|
Verastem, Inc.
|
US
|
NASDAQ
|
AJJ
|
Asian American Medical Group Ltd
|
AU
|
ASX
|
ATX
|
Amplia Therapeutics Limited
|
AU
|
ASX
|
BNO
|
Bionomics Ltd
|
AU
|
ASX
|
IMU
|
Imugene Limited
|
AU
|
ASX
|